#+TITLE: Propionic Acidemia
#+AUTHOR: Matthew Henderson, PhD, FCACB
#+DATE: \today

* Introduction
** History
- Was called Ketotic Hyperglycinemia
- A patient with PA was reported in 1961 with hyperglycinemia
  - recurrent ketoacidosis
  - \uparrow \uparrow glycine in blood and urine
  - attacks related to the intake of protein
    - administration of BCAA, Thr, Met \to ketonuria
- Index patient and sister had defective propionyl carboxylase.
- \uparrow clinical penetrance
  - incidence of PA has not \uparrow with NBS

** Propionic Acid and Derivatives

#+BEGIN_EXPORT LaTeX
\vspace{2em}
\chemname{\chemfig[][scale=.5]{-[7]-[1]([2]=O)-[7]OH}}{\tiny propionic acid}
\hspace{4em}
\chemname{\chemfig[][scale=.5]{-[7]-[1]([2]=O)-[7]CoA}}{\tiny propionyl CoA}

\vspace{2em}
\chemname{\chemfig[][scale=.5]{-N^{+}([2]-)([6]-)-[1]-[7]([6]-O-([5]=O)-[7,.6]-[1,.6])-[1]-[7]([7]=O)([1]-O^{-})}}{\tiny propionyl-carnitine}
\hspace{4em}
\chemname{\chemfig[][scale=.5]{OH-[1]-[7]-[1]([2]=O)-[7]OH}}{\tiny 3-hydroxypropionic acid}
#+END_EXPORT


** Propionic Acidemia Pathway

#+CAPTION[PA]:Propionic Acidemia
#+NAME: fig:pa
#+ATTR_LaTeX: :width 0.9\textwidth
[[./pa/figures/pa_path.png]]

** BCAA catabolism

#+CAPTION[BCAA catabolism]:BCAA catabolism
#+NAME: fig:bcaa_cat
#+ATTR_LaTeX: :width 0.9\textwidth
[[./pa/figures/bcaa.png]]

** AA catabolism

#+CAPTION[AA catabolism]: Amino Acid Catabolism
#+NAME: fig:aa_cat
#+ATTR_LaTeX: :width 0.9\textwidth
[[./pa/figures/aa_met.png]]

** Odd-Chain Length Fatty Acids

#+CAPTION[Odd-chain length FAs]: Odd-chain length fatty acids
#+NAME: fig:odd_chain
#+ATTR_LaTeX: :width 0.9\textwidth
[[./pa/figures/23_10.png]]

** Long-Chain Branched-Chain Fatty Acids

#+CAPTION[Long-Chain Branched-Chain Fatty Acids]: Long-Chain Branched-Chain Fatty Acids
#+NAME: fig:lc_bc_fa
#+ATTR_LaTeX: :width 0.9\textwidth
[[./pa/figures/ff22.png]]

- \alpha{}-oxidation of phytanic acid takes place in peroxisomes.
- Pristanic acid can then undergo \beta{}-oxidation.
   - Propionyl-CoA is released when the \alpha{} carbon is substituted

** Sterol Catabolism

#+CAPTION[Sterol Catabolism]: Sterol Catabolism
#+NAME: fig:sterol_cat
#+ATTR_LaTeX: :width 0.9\textwidth
[[./pa/figures/gr3.jpg]]

** Propionyl Carboxylase

#+CAPTION[PC]:Propionyl Carboxylase
#+NAME: fig:pc
#+ATTR_LaTeX: :width 0.9\textwidth
[[./pa/figures/pc.jpg]]

- Composed of \alpha{} and \beta{} subunits
  - \alpha{}_{4}\beta{}_{4} heteropolymer
- Apoenzyme activated by covalent binding to biotin

* Genetics and Pathogenisis

** Genetics
- autosomal recessive trait
- Two complementation groups
  - PccA \to \alpha
  - PccBC \to \beta
- \alpha{} 13q32
- \beta{} 3q13.3-22 

** Propionyl CoA
*** Hyperglycinemia
- PA inhibits synthesis of glycine cleaving enzyme.
*** CBC
- Propionyl-CoA toxic to bone marrow
  - neutropenia
  - transient thrombocytopenia in infancy
*** Hyperammonemia
- PA inhibits carbamylphosphate synthetase
*** Ketosis
- PA inhibits mitochondrial oxidation of succinic acid and 2-ketoglutaric acid

** Biochemical Markers
- 3-hydroxypropionic acid
- tiglic acid / tiglyglycine
- propionylglycine
- methylcitrate
  - condensation of propionyl-CoA & oxaloacetic acid
  - metabolic end product and very stable

* Laboratory Investigations
** NSO PA/MMA Screening Logic
*** Inital positive \lt 7 days
(C3/C2 \ge 0.21 AND C3 \ge 4.0)
OR
(C3/C2 \ge 0.23 AND C3 \ge 3.5)
*** Inital positive \gt 7 days
(C3/C2 \ge 0.21 AND C3 \ge 2.6)
OR
(C3/C2 \ge 0.23 AND C3 \ge 2.4)
  - Repeat overnight
  - No weekend reporting
*** Alert
C3/C2 \ge 0.3 AND C3 \ge 9.0
  - Repeat same day
  - Weekend reporting
*** Confirmation
 C3/C2 \ge 0.23 AND MCA \ge 0.5
** Elevated C3 ACT algorithm
#+CAPTION[C3 ACT algorithm]:C3 ACT algorithm
#+NAME: fig:c3_act
#+ATTR_LaTeX: :width 0.9\textwidth
[[./pa/figures/pa_act.png]]

** Clinical Chemistry
- Acidosis in acute episodes
  - accumulation of \beta-hydroxybutyrate and acetoacetate
  - Arterial pH as low as 6.9
  - Bicarb as low as 5 mEq/L
- \uparrow lactic acid
- Hypoglycemia
- Hyperammonemia 

** Biochemical Genetics
*** Plasma Amino Acids
- \Uparrow glycine
- \uparrow glutamine when hyperammonemia
*** Plasma Acylcarnitines
- \uparrow propionyl carnitine (C3)
*** Urine Organic Acids
- 3-hydroxypropionic acid
- methylcitric acid
- lactic acid
- BHB
- acetoacetate
- tiglic acid / tiglyglycine

** Urine Organic Acids
#+CAPTION[pa OAs]:PA Organic Acids
#+NAME: fig:pa_oa
#+ATTR_LaTeX: :width 0.9\textwidth
[[./pa/figures/pa_uoa.png]]

* Clinical Findings
** Acute presentation
- Life-threatening illness early in life
  - ketonuria
    - acidosis
    - dehydration
  - vomiting
  - lethargy \to coma

** Recurrent Symptoms
- ketotic episodes
- infection
- protein intolerance

** Long term 
- Variable developmental/cognitive outcomes
  - appears linked to incidence of illness
- hypotonic
  - developmental delay
- A subset with exclusively neurological presentation
  - \pm ketoacidosis
  - hypotonia \to hypertonia
- Propionyl-CoA toxic to bone marrow
  - neutropenia
  - transient thrombocytopenia in infancy
- Osteoporosis
- Pancreatitis
- Cardiomyopathy
- Fatty infiltration of liver on PM

** Neurological Findings
- Neonatal death
  - spongy degeneration of white matter
- Later death
  - shrinkage and marbling in basal ganglia
  - neuronal loss
  - gliosis

#+CAPTION[PA MRI]:PA MRI
#+NAME: fig:mri
#+ATTR_LaTeX: :width 0.9\textwidth
[[./pa/figures/pa_mri.png]]

** Long-term Treatment
*** Diet
- Limit Val, Ile, Thr, Met
  - Monitor urine metabolites, plasma amino acids
  - Urine ketones (daily in infancy)
  - Monitor weight, nitrogen balance
- Avoid fasting
  - Catabolism
  - Propionate release from lipids

*** Supplementation
- Carnitine
  - excretion of carnitine esters \to detoxification
  - Daily dose 60 to 100 mg/kg 
- Biotin
  - conflicting information

  
